Dia-Stron

Closed
Call
Website
888 Sussex Blvd Ste 3
Broomall, PA 19008
+1 (610) 328-9038
https://www.diastron.com

Dia-Stron is a leading manufacturer of automated measurement systems specializing in single fibres and filaments, catering to diverse applications including hair, natural, and synthetic fibre testing. With a comprehensive approach to metrology, the company focuses on the design and development of scientific systems to enhance productivity and data quality.

Headquartered in the United Kingdom with facilities in Andover and offices in the USA, Dia-Stron is renowned for its expertise in fibre testing, supporting clients worldwide through contract testing services and innovative instrumentation. Their commitment to reliability and customer service ensures that they remain a trusted partner in research and development across various industries.

Generated from the website

Also at this address

Own this business?
See a problem?

You might also like

Sizes

Civi Biopharma

Everight Position Tech Corp
Industrial supplies, nec, Feathers and feather products

Everight Position Tech Corp

Everight Position is dedicated to helping customers find the best rotary, linear, tilt and liquid level sensor solutions for their positioning needs. By working with engineers one-on-one to understand their application, Everight Position offers unique and innovative solutions.
Drugs acting on the respiratory system

Madrigal Pharmaceuticals, Inc

Madrigal Pharmaceuticals, Inc. is a biopharmaceutical company based in Conshohocken, PA, dedicated to developing innovative therapeutics for non-alcoholic steatohepatitis (NASH), also known as metabolic dysfunction associated steatohepatitis (MASH). Their primary focus lies in creating treatments for adults with NASH exhibiting moderate to advanced liver fibrosis, with ongoing research in Phase 3 trials for those with compensated cirrhosis. With the recent FDA accelerated approval of their first therapy, Madrigal Pharmaceuticals is at the forefront of pioneering treatments for NASH/MASH patients. The company's ambitious research endeavors have resulted in groundbreaking advancements, leading to the development of the first FDA-approved medication specifically tailored to address the challenges faced by patients with NASH. Generated from the website content
United States›Pennsylvania›Broomall›Dia-Stron

Partial Data by Foursquare.